A novel stemness classification in acute myeloid leukemia by the stemness index and the identification of cancer stem cell-related biomarkers

A novel stemness classification in acute myeloid leukemia by the stemness index and the identification of cancer stem cell-related biomarkers

BackgroundStem cells play an important role in acute myeloid leukemia (AML). However, their precise effect on AML tumorigenesis and progression remains unclear.MethodsThe present study aimed to characterize stem cell-related gene expression and identify stemness biomarker genes in AML. We calculated...

Full description

Bibliographic Details
Main Authors:	Yue Huang, Zhuo Zhang, Meijuan Sui, Yang Li, Yi Hu, Haiyu Zhang, Fan Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Immunology
Subjects:	AML cancer stem cell mRNAsi biomarkers SLC43A2
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1202825/full

Similar Items

Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices
by: Shen Pan, et al.
Published: (2019-07-01)

Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis
by: Jianying Pei, et al.
Published: (2020-02-01)

Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinoma
by: Han Wang, et al.
Published: (2022-12-01)

Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma
by: Shaohui Hou, et al.
Published: (2022-04-01)

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma
by: Xiong Tian, et al.
Published: (2022-07-01)

Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis
by: Yao Kang, et al.
Published: (2021-03-01)

Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma
by: XiaoFang Wang, et al.
Published: (2023-09-01)

Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds
by: Haoming Mai, et al.
Published: (2022-01-01)

Integrative Analysis of Gene Expression Through One-Class Logistic Regression Machine Learning Identifies Stemness Features in Multiple Myeloma
by: Chunmei Ban, et al.
Published: (2021-08-01)

Potential Role of S-Palmitoylation in Cancer Stem Cells of Lung Adenocarcinoma
by: Yitong Zhang, et al.
Published: (2021-09-01)

Exploring the role of tumor stemness and the potential of stemness-related risk model in the prognosis of intrahepatic cholangiocarcinoma
by: Yuan Yue, et al.
Published: (2023-01-01)

Identification of cancer stem cell-related biomarkers in intestinal-type and diffuse-type gastric cancer by stemness index and weighted correlation network analysis
by: Rui Guo, et al.
Published: (2020-11-01)

Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index
by: Kun‐Hao Bai, et al.
Published: (2020-06-01)

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
by: Zhihang Wang, et al.
Published: (2022-03-01)

Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
by: Yuxin Wang, et al.
Published: (2023-08-01)

mRNAsi-related metabolic risk score model identifies poor prognosis, immunoevasive contexture, and low chemotherapy response in colorectal cancer patients through machine learning
by: Meilin Weng, et al.
Published: (2022-08-01)

mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes
by: Canbiao Wang, et al.
Published: (2022-01-01)

scRNA-seq revealed high stemness epithelial malignant cell clusters and prognostic models of lung adenocarcinoma
by: GuoYong Lin, et al.
Published: (2024-02-01)

Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Breast Invasive Carcinoma
by: Runzhi Huang, et al.
Published: (2021-01-01)

An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma
by: Guihua Tang, et al.
Published: (2023-06-01)

Emerging and Future Targeted Therapies for Pediatric Acute Myeloid Leukemia: Targeting the Leukemia Stem Cells
by: Lindsey A. Murphy, et al.
Published: (2023-12-01)

CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia
by: Yongliang Liu, et al.
Published: (2021-01-01)

Molecular Mechanisms in Murine Syngeneic Leukemia Stem Cells
by: Michael Chamo, et al.
Published: (2023-01-01)

PHF6 loss reduces leukemia stem cell activity in an acute myeloid leukemia mouse model
by: Shengnan Yuan, et al.
Published: (2024-02-01)

CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia
by: Lixiazi He, et al.
Published: (2022-04-01)

Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells
by: Haijun Zhao, et al.
Published: (2022-05-01)

Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target
by: Alberto Quattrocchi, et al.
Published: (2023-12-01)

Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation
by: Christina Rautenberg, et al.
Published: (2020-08-01)

Understanding the Notch Signaling Pathway in Acute Myeloid Leukemia Stem Cells: From Hematopoiesis to Neoplasia
by: Daniel Láinez-González, et al.
Published: (2022-03-01)

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
by: Fayyad-Kazan Hussein, et al.
Published: (2013-02-01)

Lysosomes in Stem Cell Quiescence: A Potential Therapeutic Target in Acute Myeloid Leukemia
by: Vaibhav Jain, et al.
Published: (2022-03-01)

Understanding the Hedgehog Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Necessary Step toward a Cure
by: Daniel Lainez-González, et al.
Published: (2021-03-01)

Rare myeloid sarcoma/acute myeloid leukemia with adrenal mass after allogeneic mobilization peripheral blood stem cell transplantation
by: Ya-Fei Wang, et al.
Published: (2013-12-01)

Acute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem Cells
by: Josephine Wesely, et al.
Published: (2020-06-01)

DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia
by: Guo‐Kang Sun, et al.
Published: (2019-10-01)

Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective study
by: Lu Gao, et al.
Published: (2024-01-01)

Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection
by: Kritika Srinivasan Rajsri, et al.
Published: (2023-05-01)

Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia
by: Yong Liu, et al.
Published: (2023-01-01)

Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid Leukemia
by: Azza M. Kamel, et al.
Published: (2022-04-01)

Jiyuan oridonin A induces differentiation of acute myeloid leukemia cells including leukemic stem-like cells
by: Fahui Li, et al.
Published: (2022-09-01)